A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
暂无分享,去创建一个
J. Schatz | M. Schmelz | J. Guillén-Rodríguez | D. Persky | S. Puvvada | L. Inclán | K. Heard | Xavier I. Rivera | Lora Inclán | José M. Guillén-Rodríguez